Ali Mohammadi
- Cancer Research top 0.5%
- MicroRNA in disease regulation 60
- Cancer-related molecular mechanisms research 30
- Molecular Biology top 2%
- Circular RNAs in diseases 28
- RNA Interference and Gene Delivery 27
- RNA modifications and cancer 10
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery 10
- Oncology top 2%
- Cancer Cells and Metastasis 11
- Drug Discovery top 2%
-
- Nanoplatforms for cancer theranostics 10
Ali Mohammadi
131 papers receiving 5.9k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Cancer Research 2.2k
- Molecular Biology 3.6k
- Biomaterials 547
- Oncology 1.0k
- Drug Discovery 5
Countries citing papers authored by Ali Mohammadi
This map shows the geographic impact of Ali Mohammadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Mohammadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Mohammadi more than expected).
Fields of papers citing papers by Ali Mohammadi
This network shows the impact of papers produced by Ali Mohammadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Mohammadi. The network helps show where Ali Mohammadi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ali Mohammadi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 19 | |
| 2 | 2021 | 3 | |
| 3 | 2021 | 37 | |
| 4 | 2021 | 4 | |
| 5 | 2020 | 14 | |
| 6 | 2020 | 30 | |
| 7 | 2020 | 8 | |
| 8 | 2020 | 2 | |
| 9 | 2020 | 80 | |
| 10 | 2020 | 18 | |
| 11 | 2019 | 15 | |
| 12 | 2019 | 42 | |
| 13 | 2019 | 19 | |
| 14 | 2019 | 37 | |
| 15 | 2018 | 26 | |
| 16 | 2018 | 7 | |
| 17 | 2018 | 36 | |
| 18 | 2018 | 81 | |
| 19 | Extracts of Scrophularia frigida Boiss display potent antitumor effects in human breast cancer cells by inducing apoptosis and inhibition of expression of the human epidermal growth factor receptor 2. | 2016 | 3 |
| 20 | CYTOTOXIC EFFECTS OF ANACYCLUS PYRETHRUM PLANT EXTRACT IN ORAL CANCER CELL (KB CELL LINE) | 2016 | 2 |
About Ali Mohammadi
Ali Mohammadi is a scholar working on Cancer Research, Molecular Biology and Complementary and alternative medicine, having authored 135 papers that have together received 6.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (60 papers), Cancer-related molecular mechanisms research (30 papers), Circular RNAs in diseases (28 papers), RNA Interference and Gene Delivery (27 papers), Cancer Cells and Metastasis (11 papers), Nanoplatforms for cancer theranostics (10 papers), RNA modifications and cancer (10 papers) and Nanoparticle-Based Drug Delivery (10 papers). The work is most often cited by research in Cancer Research (2.2k citations), Molecular Biology (3.6k citations) and Biomaterials (547 citations). Ali Mohammadi has collaborated with scholars based in Iran, Denmark and Australia. Frequent co-authors include Behzad Mansoori, Behzad Baradaran, Solmaz Shirjang, Sadaf Davudian, Pascal H. G. Duijf, Morten F. Gjerstorff, Ahad Mokhtarzadeh, Dariush Shanehbandi, Vahid Khaze and Tohid Kazemi.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.